NCT00300521
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Beijing Chao Yang Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,030 public trials
1,171 recruiting studies
Adenocarcinoma trial results
NCT00291369
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Centre Leon Berard Lyon, France
NCT00273247
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +25 more
- Locations
-
- National Cancer Institute Milan, Italy
NCT00149565
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Chang Gung Memorial Hospital Taoyuan, Taiwan
Completed
Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC
NCT00234182
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
Not specified
NCT00154817
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Completed
Qidong Hepatitis B Intervention Study
NCT00222664
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +17 more
- Locations
-
- Qidong Liver Cancer Institute Qidong, Jiangsu, China
- Cancer Institute, Chinese Academy of Medical Sciences Beijing, China
- Clinical Trial Service Unit and Epidemiological Studies Unit Oxford, United Kingdom
NCT00006332
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- 3912 Taubman Center Ann Arbor, Michigan, United States
NCT00041808
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
- Locations
-
- Scripps Stevens Cancer Division San Diego, California, United States
- UCSF Cancer Center San Francisco, California, United States
- Scott and White Clinic Temple, Texas, United States
- Frankfurt Universtiy Frankfurt, Germany
Active, Not Recruiting
Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors
NCT03878095
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
- Yale University New Haven, Connecticut, United States
- Smilow Cancer Hospital Care Center-Trumbull Trumbull, Connecticut, United States